Scope, Modalities, Format and Organization of the High-Level Plenary Meeting on Antimicrobial Resistance Convened by the President of the General Assembly

A/RES/70/297View PDF

Who adopted this document and its mandates?

A Resolution of the General Assembly, under agenda item 125 Global health and foreign policy, published in 2016.

What other versions does this mandate have?

2 versions · 2016–2024

This is an older version — the most recent is A/RES/78/269

Year	Symbol	Title	Word length	Text similarity
2024	A/RES/78/269	Scope, modalities, format and organization of the High-Level Plenary Meeting on Antimicrobial Resistance convened by the President of the General Assembly	2,103	26%Compare
2016	A/RES/70/297	Scope, modalities, format and organization of the High-Level Plenary Meeting on Antimicrobial Resistance convened by the President of the General Assembly	958	–

What subjects does this mandate have?

3 subjects

Conferences Disease Prevention Health

What’s in this document?

16 operative paragraphs

Decides that the high-level meeting on antimicrobial resistance convened by the President of the General Assembly shall be held in New York on 21 September 2016, from 10 a.m. to 1 p.m. and from 3 to 6 p.m.;

Encourages all Member and observer States to participate in the high-level meeting at the highest possible level, preferably at the level of Heads of State and Government;

Decides that the organizational arrangements of the high-level meeting shall be as follows:

The opening segment will include statements by the President of the General Assembly, the Secretary-General, the Director General of the World Health Organization, the Director General of the Food and Agriculture Organization of the United Nations and the Director General of the World Organization for Animal Health, each speaking from his or her perspective and in accordance with the mission and mandate that each institution represents;

Two interactive hour-long thematic panels will be held, each composed of up to six discussants, with three Heads of State and Government and three relevant stakeholders each, bearing in mind equitable gender, level of development and geographical representation, on the following themes:

Panel 1: Relevance of addressing antimicrobial resistance for the achievement of the Sustainable Development Goals, in particular the health-related Goals

Panel 2: Addressing the multisectoral implications and implementation challenges of antimicrobial resistance in a comprehensive manner

Panels 1 and 2 will be held during the morning session, in parallel with the plenary segment;

The plenary segment for general discussions during the morning and the afternoon sessions will comprise three-minute interventions by Member and observer States and observers. A list of speakers will be established in accordance with the rules of procedure and practices of the General Assembly;

The closing segment by the President of the General Assembly will comprise summaries of the thematic panel discussions and concluding remarks;

Requests the President of the General Assembly, with the support of the World Health Organization, the Food and Agriculture Organization of the United Nations and the World Organization for Animal Health, to finalize the organizational arrangements for the thematic panels, taking into account the views of Member States and equitable gender, level of development and geographical representation, for the participation of Heads of State and Government, as well as of relevant civil society, private sector, academia and other stakeholders with expertise in antimicrobial resistance;

Requests the facilitator of the consultations to lead an informal interactive dialogue with relevant civil society and private sector stakeholders with expertise in antimicrobial resistance, as part of the preparatory process for the high-level meeting;

Invites all relevant United Nations system entities, including programmes, funds, specialized agencies and regional commissions, as well as regional and subregional organizations, to participate in the high-level meeting, contributing as appropriate, and to consider initiatives in support of its preparatory process;

Invites intergovernmental organizations and related entities that have observer status with the General Assembly to be represented at the highest possible level;

Invites non-governmental organizations that are in consultative status with the Economic and Social Council with relevant expertise to register with the Secretariat to attend the meeting;

Encourages Member States to consider, as appropriate, including in their national delegations parliamentarians and civil society, private sector, academia and other stakeholders working on antimicrobial resistance;

Requests the President of the General Assembly to draw up a list of other relevant representatives of relevant non-governmental organizations, civil society organizations, academic institutions and the private sector with expertise in antimicrobial resistance who may attend the high-level meeting and participate in the interactive panel discussions, taking into account the principles of transparency and of equitable geographical representation, and with due regard to the meaningful participation of women, and to submit the list to Member States for their consideration on a non-objection basis;⁴

⁴The list of proposed as well as final names will be brought to the attention of the General Assembly. Where a name is objected to, the objecting Member State will, on a voluntary basis, make known to the Office of the President of the General Assembly the general basis of its objections and the Office will share any information received with any Member State upon its request.

Decides that the high-level meeting shall approve a concise and action-oriented declaration, agreed by consensus through intergovernmental consultations, to be submitted by the President of the General Assembly for adoption by the Assembly.

Who adopted this document and its mandates?

What other versions does this mandate have?

What subjects does this mandate have?

What’s in this document?

Table of contents